STIM1
Stromal interaction molecule 1
Also known as: D11S4896E, GOK, STIM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13586
- Gene
- STIM1
- Ensembl
- ENSG00000167323
- Chromosome
- 11
- Canonical length
- 685 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Endoplasmic reticulum
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene encodes a type 1 transmembrane protein that mediates Ca2+ influx after depletion of intracellular Ca2+ stores by gating of store-operated Ca2+ influx channels (SOCs). It is one of several genes located in the imprinted gene domain of 11p15.5, an important tumor-suppressor gene region. Alterations in this region have been associated with the Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocrotical carcinoma, and lung, ovarian, and breast cancer. This gene may play a role in malignancies and disease that involve this region, as well as early hematopoiesis, by mediating attachment to stromal cells. Mutations in this gene are associated with fatal classic Kaposi sarcoma, immunodeficiency due to defects in store-operated calcium entry (SOCE) in fibroblasts, ectodermal dysplasia and tubular aggregate myopathy. This gene is oriented in a head-to-tail configuration with the ribonucleotide reductase 1 gene (RRM1), with the 3' end of this gene situated 1.6 kb from the 5' end of the RRM1 gene. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
Canonical amino-acid sequenceUniProt
685 residues, UniProt reviewed canonical sequence.
>Q13586|STIM1
1 MDVCVRLALW LLWGLLLHQG QSLSHSHSEK ATGTSSGANS EESTAAEFCR IDKPLCHSED
61 EKLSFEAVRN IHKLMDDDAN GDVDVEESDE FLREDLNYHD PTVKHSTFHG EDKLISVEDL
121 WKAWKSSEVY NWTVDEVVQW LITYVELPQY EETFRKLQLS GHAMPRLAVT NTTMTGTVLK
181 MTDRSHRQKL QLKALDTVLF GPPLLTRHNH LKDFMLVVSI VIGVGGCWFA YIQNRYSKEH
241 MKKMMKDLEG LHRAEQSLHD LQERLHKAQE EHRTVEVEKV HLEKKLRDEI NLAKQEAQRL
301 KELREGTENE RSRQKYAEEE LEQVREALRK AEKELESHSS WYAPEALQKW LQLTHEVEVQ
361 YYNIKKQNAE KQLLVAKEGA EKIKKKRNTL FGTFHVAHSS SLDDVDHKIL TAKQALSEVT
421 AALRERLHRW QQIEILCGFQ IVNNPGIHSL VAALNIDPSW MGSTRPNPAH FIMTDDVDDM
481 DEEIVSPLSM QSPSLQSSVR QRLTEPQHGL GSQRDLTHSD SESSLHMSDR QRVAPKPPQM
541 SRAADEALNA MTSNGSHRLI EGVHPGSLVE KLPDSPALAK KALLALNHGL DKAHSLMELS
601 PSAPPGGSPH LDSSRSHSPS SPDPDTPSPV GDSRALQASR NTRIPHLAGK KAVAEEDNGS
661 IGEETDSSPG RKKFPLKIFK KPLKKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STIM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 105 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 105 nTPM
- thymus: 63 nTPM
- esophagus: 62 nTPM
- salivary gland: 55 nTPM
- tongue: 47 nTPM
- thyroid gland: 44 nTPM
Single-cell type
- neutrophil progenitors: 770 nCPM
- neutrophils: 724 nCPM
- thymic myoid cells: 621 nCPM
- myonuclei: 526 nCPM
- salivary acinar cells: 364 nCPM
- thymocytes: 358 nCPM
Immune cell
- non-classical monocyte: 25 nTPM
- NK-cell: 21 nTPM
- memory CD8 T-cell: 20 nTPM
- eosinophil: 20 nTPM
- gdT-cell: 18 nTPM
- total PBMC: 16 nTPM
Brain region
- cerebral cortex: 74 nTPM
- amygdala: 71 nTPM
- basal ganglia: 67 nTPM
- choroid plexus: 63 nTPM
- hypothalamus: 58 nTPM
- thalamus: 55 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about STIM1.
Disease | AllUniProt
Conditions STIM1 is implicated in, by any mechanism.
- Immunodeficiency 10 (IMD10) MIM:612783
- Myopathy, tubular aggregate, 1 (TAM1) MIM:160565
- Stormorken syndrome (STRMK) MIM:185070
Disease | GeneticClinVar
37 pathogenic / likely-pathogenic of 909 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Combined immunodeficiency due to STIM1 deficiency
- Stormorken syndrome
- Myopathy with tubular aggregates
- Myopathy, tubular aggregate, 1
- Myopathy, autophagic vacuolar, infantile-onset
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.78
- gnomAD missense Z
- 2.12
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of store-operated calcium channel activity
- detection of calcium ion
- enamel mineralization
- intracellular calcium ion homeostasis
- positive regulation of adenylate cyclase activity
- positive regulation of angiogenesis
- regulation of calcium ion transport
- regulation of store-operated calcium entry
- store-operated calcium entry
Molecular functions
- calcium channel regulator activity
- calcium ion binding
- identical protein binding
- microtubule plus-end binding
- protease binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STIM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STIM1 as an antibody target. Whether an autoantibody or antibody against STIM1 could matter depends on whether native STIM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STIM1 is annotated at the cell surface, where native STIM1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label STIM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...